LEGACY PHARMA INVEST GP INC.
LEGACY PHARMA INVEST GP INC. is a Pre-seed, Seed, Series C+ and buyout fund in the US and Europe investing in AI, Healthcare, pharmaceuticals, healthcare-tech, medical-devices and diagnostics.
- Stages
- Pre-seed, Seed, Series C+, buyout
- Sectors
- AI, Healthcare, pharmaceuticals, healthcare-tech, medical-devices, diagnostics
- Invests in
- US-wide, Europe
Check size not disclosed
Thesis
While the provided text does not list specific investments for this entity, it details the investment theses of related "Legacy" entities. Legacy Venture Capital focuses on life sciences startups at the pre-seed and seed stages, targeting areas like Performance, Vitality, Longevity, and Quality of Life, with specific interests in pharmaceuticals (oncology, rare disease, neuroscience), AI-powered platforms, medical devices, and diagnostics. Legacy Partners targets pharmaceutical and med-tech companies with differentiated products addressing unmet medical needs, preferring those with approved products and a focus on European companies needing US market entry. Legacy Capital acquires and scales overlooked legacy businesses in recession-resilient, tech-enabled industries such as Transportation & Logistics, Healthcare Tech & Services, and Digital Infrastructure. The typical check size for LEGACY PHARMA INVEST GP INC. is not explicitly stated, but related entities suggest smaller initial investments for early-stage companies and a range of sizes for more established ones.
Common questions
Does LEGACY PHARMA INVEST GP INC. invest at the Pre-seed stage?
Yes. LEGACY PHARMA INVEST GP INC. lists Pre-seed, Seed, Series C+ and buyout among the stages it invests in.
Where does LEGACY PHARMA INVEST GP INC. invest?
LEGACY PHARMA INVEST GP INC. invests in the US and Europe.